Companies /Healthcare

Quantum Cyber N.V.

NASDAQ: QUCY Diagnostics & Research

$1.38

▼ $0.02 (−1.08%) today

Markets open · 10:27am ET

QUCY at a Glance

Valuation

Market cap: $116.9M

Profitability

Revenue (TTM): $537,080
EPS (TTM): $-2.41

Price

52-week range: $0 – $5
Street target: $9.00

Earnings

Next report: Nov 13, 2026

Headquartered in Robert Koch Strasse 50, Mainz Fiscal year ends December NASDAQ: QUCY quantum-cyber.ai

About Quantum Cyber

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.

QUCY Coverage

11:05am ET

Investing

SpaceX Is Down 17% This Week. What Could Push It Back Up to $225?

Shares of SpaceX (NASDAQ:SPCX | SPCX Price Prediction) are trading lower again on Friday morning, with the stock changing hands at $152. That extends a rough stretch in which SpaceX stock has…

ILLR QUCY SPCX

David Moadel

Frequently Asked Questions

What does Quantum Cyber do?

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.

What is the QUCY stock price target?

The Wall Street consensus 12-month price target for QUCY is $9.00.